Voraxaze

Chemical Nameglucarpidase
Dosage FormInjection (intravenous; 1000 units/vial)
Drug ClassEnzymes
SystemUrinary
CompanyBTG International Inc.
Approval Year2012

Indication

  • For the treatment of toxic plasma methotrexate concentrations (>1 micromole per liter) in patients with delayed methotrexate clearance due to impaired renal function.
Last updated on 5/10/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Voraxaze (glucarpidase) Prescribing Information2012BTG International Inc. Brentwood, TN